Annotated Medicine and Device Lists

Didanosine (ddI)

Capsule 400 mg Capsule (unbuffered enteric-coated) 125 mg Capsule (unbuffered enteric-coated) 200 mg Capsule (unbuffered enteric-coated) 250 mg Capsule (unbuffered enteric-coated) 400 mg N/A Powder for oral administration 4g Powder for oral liquid 10mg/ml 2g Powder for solution 2 g Solid oral dosage form 100mg Solid oral dosage form 250mg Solid oral dosage form 400mg Tablet 400 mg Tablet 250 mg Tablet 100 mg Tablet 100-400mg Tablet (buffered chewable, dispersible) 100 mg

This medicine is present in:

List	Section	Observation
Barbados. Barbados National Drug Formulary (BNDF)	08.18.08.20 Nucleoside Reverse Transcriptase Inhibitors	No observations

This medicine is present in:

List	Section	Observation
El Salvador - 2019	ANTIVIRALES DE USO SISTÉMICO	No observations

This medicine is present in:

List	Section	Observation
Mexico. Cuadro Basico de Medicamentos - 2017	06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS	No observations

This medicine is present in:

List	Section	Observation
Mexico. Cuadro Basico de Medicamentos - 2017	06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS	No observations
El Salvador - 2019	ANTIVIRALES DE USO SISTÉMICO	No observations

This medicine is present in:

List	Section	Observation
Mexico. Cuadro Basico de Medicamentos - 2017	06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS	No observations
El Salvador - 2019	ANTIVIRALES DE USO SISTÉMICO	No observations

This medicine is present in:

List	Section	Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016	Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC	Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS

This medicine is present in:

List	Section	Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020	J. ANTI-INFECCIOSOS PARA USO SISTEMICO	No observations
El Salvador - 2019	ANTIVIRALES DE USO SISTÉMICO	No observations
Chile. Formulario Nacional de Medicamentos. 2005	06.05. ANTIVIRALES	No observations

This medicine is present in:

List	Section	Observation
Peru	6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors	No observations

This medicine is present in:

List	Section	Observation
Belize. National Drug Formulary	06.04.02.01 Nucleoside reverse transcriptase inhibitors	No observations

This medicine is present in:

List	Section	Observation
Peru	6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors	No observations

This medicine is present in:

List	Section	Observation
Barbados. Barbados National Drug Formulary (BNDF)	08.18.08.20 Nucleoside Reverse Transcriptase Inhibitors	No observations

This medicine is present in:

List	Section	Observation
Peru	6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors	No observations

This medicine is present in:

List	Section	Observation
Paraguay. Lista de Medicamentos Esenciales. 2009	05. ANTIVIRALES DE USO SISTÉMICO	No observations
Chile. Formulario Nacional de Medicamentos. 2005	06.05. ANTIVIRALES	No observations
Barbados. Barbados National Drug Formulary (BNDF)	08.18.08.20 Nucleoside Reverse Transcriptase Inhibitors	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	05.03.01 Nucleoside Reverse Transcriptase Inhibitors Analogues (NRTIs)	No observations

This medicine is present in:

List	Section	Observation
Chile. Formulario Nacional de Medicamentos. 2005	06.05. ANTIVIRALES	No observations

This medicine is present in:

List	Section	Observation
Paraguay. Lista de Medicamentos Esenciales. 2009	05. ANTIVIRALES DE USO SISTÉMICO	No observations
Chile. Formulario Nacional de Medicamentos. 2005	06.05. ANTIVIRALES	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Mexico. Cuadro Basico de Medicamentos - 2017	06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS	No observations

Information Resources: Didanosine (ddI)

No information available